In Re Classen Immunotherapies, Inc.

Federal Circuit

In Re Classen Immunotherapies, Inc.

CourtCourt of Appeals for the Federal Circuit

DecidedNovember 20, 2012

Docket2012-1141

StatusUnpublished

This text of In Re Classen Immunotherapies, Inc. (In Re Classen Immunotherapies, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

In Re Classen Immunotherapies, Inc., (Fed. Cir. 2012).

Pincite

Opinion

NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________

IN RE CLASSEN IMMUNOTHERAPIES, INC.

____________________

2012-1141 (Reexamination No. 90/007,638) ______________________

Appeal from the United States Patent and Trademark Office, Board of Patent Appeals and Interferences. ______________________

JUDGMENT ______________________

JOSEPH J. ZITO, Zito tlp, of Washington, DC, argued for appellant.

NATHAN K. KELLEY, Deputy Solicitor, United States Patent and Trademark Office, of Alexandria, Virginia, argued for Director of the United States Patent and Trademark Office. With him on the brief were RAYMOND T. CHEN, Solicitor, and THOMAS W. KRAUSE, Associate Solicitor. ______________________ THIS CAUSE having been heard and considered, it is

ORDERED and ADJUDGED:

PER CURIAM (NEWMAN, MOORE, and REYNA, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

November 20, 2012 /s/ Jan Horbaly Date Jan Horbaly Clerk

Free access — add to your briefcase to read the full text and ask questions with AI